Key result
Obesity is linked to ~57% higher CVD prevalence in adults with type 2 diabetes.
Why the study?
Obesity may contribute to insulin resistance and an adverse cardiometabolic profile in adults with type 2 diabetes, but associations with established complications require careful interpretation because age, diabetes duration, and treatment may influence both body weight and outcomes.
Does obesity (BMI ≥30 kg/m²) associate with poorer glycemic control, higher systolic blood pressure, greater insulin resistance, and higher prevalence of cardiovascular and microvascular complications compared to BMI <30 kg/m² in adults with type 2 diabetes?
Cross-Sectional (n=200)
Does obesity (BMI ≥30 kg/m²) associate with poorer glycemic control, higher systolic blood pressure, greater insulin resistance, and higher prevalence of cardiovascular and microvascular complications compared to BMI <30 kg/m² in adults with type 2 diabetes?
In this cross-sectional analysis of adults with type 2 diabetes, obesity (BMI ≥30 kg/m²) was associated with poorer unadjusted glycemic control, higher systolic blood pressure, higher HOMA-IR, and a 57% higher crude prevalence of cardiovascular disease, though results are limited by unmeasured confounding and missing methodological documentation.
Answers are grounded in this paper and cite their sources.
Obesity-linked higher CVD prevalence in type 2 diabetes warrants prospective confirmation; leaves open causal effects and intervention benefits.
Background: Obesity may contribute to insulin resistance and an adverse cardiometabolic profile in adults with type 2 diabetes. Associations with established complications require careful interpretation because age, diabetes duration and treatment may influence both body weight and outcomes. Objective: To compare glycemic control, systolic blood pressure, insulin resistance and reported diabetic complications between adults with and without obesity. Methods: The source manuscript described a cross-sectional study of 200 adults aged 30–75 years with type 2 diabetes. Participants were compared using BMI ≥30 kg/m² (n=120) and BMI <30 kg/m² (n=80). This revision reconstructed unadjusted Welch t tests from group means and standard deviations. Complication prevalence ratios were estimated only where reported percentages corresponded to integer counts, assuming complete group denominators. Results: Participants with obesity had higher mean HbA1c (8.1 ± 1.3% versus 7.4 ± 1.1%), systolic blood pressure (140.5 ± 12.7 versus 130.4 ± 11.9 mmHg) and HOMA-IR (12.5 ± 4.1 versus 8.3 ± 3.2); reconstructed p values were <0.001 for all three comparisons. Cardiovascular disease prevalence was 55% versus 35%, corresponding to a crude prevalence ratio of 1.57 (95% CI 1.12–2.21). Neuropathy prevalence was 20% versus 15% (prevalence ratio 1.33; 95% CI 0.71–2.51). Nephropathy was reported in approximately 18% versus 12%; exact event counts were unavailable. Conclusion: The reported summaries associated obesity with poorer metabolic measures and higher cardiovascular disease prevalence.
No takes yet. Share an insight, caveat, or question.
Moiza Faizi, Ayesha Tahreem, Dhanak Fatima, Muhammad Badar Ul Zaman, Urooba Javaid, Muhammad Abdullah, Uzma Batool (2026) conducted a cross-sectional in Type 2 diabetes (n=200). Obesity (BMI >=30 kg/m²) vs. Non-obesity (BMI <30 kg/m²) was evaluated on Prevalence of cardiovascular disease (PR 1.57, 95% CI 1.12-2.21, p=0.005). Obesity (BMI >=30 kg/m²) was associated with a 57% higher prevalence of cardiovascular disease compared to BMI <30 kg/m² in adults with type 2 diabetes.
Synapse has enriched 10 related papers. Consider them for comparative context: